Intellipharmaceutics International Inc. (IPCI)

[doogdilinger]

The pre-reverse split share price equivalent of .02 cents is about to fall as the share price erosion continues unabated.

Now both the round 1 and round 2 shareholders have been crucified by this CEO's woeful mismanagement and incompetence.

I keep saying that there may be a dead cat bounce here when it hits a dime...but that's only if this CEO can actually refile Rexista. For all we know he's not even gonna resubmit Rexista due to undisclosed problems encountered he's failing to inform the market about the same way he failed to properly disclose the CRL's he received on ANDA's in a remotely timely fashion!

The next lawsuit meeting/exchange with Purdue over Rexista was supposed to occur sometime this month if memory serves...but I have no clue why it was delayed until December in the 1st place. I don't see Purdue worried about Rexista one iota though since it's been a year and a half since the failed Rexista adcom and so far this company can't even refile their Rexista NDA candidate with the FDA...so even if they do refile Rexista soon...by the time they even get granted another adcom it's gonna be next summer anyways...and Purdue's Oxy patent expires in August anyways...so why is the lawsuit not already settled instead of IPCI continuing to spend money fighting it?